Ahmed s Saad
Professor of OB & GYN · Benha University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ahmed s Saad as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:50 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07736261 · Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSIAhmed Saad · not yet recruiting · Poor Ovarian Reserve, Infertility (IVF Patients) · study director
- Ph1/Ph2NCT06608186 · Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!Ahmed Saad · completed · PCOS (Polycystic Ovary Syndrome) · study director
- Ph1NCT02814695 · Yeast Cells as Antioxidant-Producing ProbioticsBenha University · completed · Infertility, Male · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:50 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Metformin Addition to Chemotherapy in Stage IV Non-Small Cell Lung Cancer: an Open Label Randomized Controlled Study.Asian Pac J Cancer Prev · 201554 citationsRCR 1.8
- L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways.Toxicol Appl Pharmacol · 201948 citationsRCR 2.5
- Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.Lancet Gastroenterol Hepatol · 201948 citationsRCR 1.9
- 36 citationsRCR 2.0
- A Randomized Controlled Open-Label Pilot Study of Simvastatin Addition to Whole-Brain Radiation Therapy in Patients With Brain Metastases.Oncol Res · 201621 citationsRCR 0.8
- 21 citationsRCR 1.2
- A prospective randomized controlled study of cisplatin versus carboplatin-based regimen in advanced squamous nonsmall cell lung cancer.J Cancer Res Ther · 201710 citationsRCR 0.3